Page last updated: 2024-09-03

ginsenoside rh2 and honokiol

ginsenoside rh2 has been researched along with honokiol in 1 studies

Compound Research Comparison

Studies
(ginsenoside rh2)
Trials
(ginsenoside rh2)
Recent Studies (post-2010)
(ginsenoside rh2)
Studies
(honokiol)
Trials
(honokiol)
Recent Studies (post-2010) (honokiol)
29512008161586

Protein Interaction Comparison

ProteinTaxonomyginsenoside rh2 (IC50)honokiol (IC50)
Neuraminidase Influenza A virus (A/Wilson-Smith/1933(H1N1))1.39
TPA: protein transporter TIM10Saccharomyces cerevisiae S288C48.8
high affinity choline transporter 1 isoform aHomo sapiens (human)12.0226
Polyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)4.2
Prostaglandin G/H synthase 2Ovis aries (sheep)2.1

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Cai, N; Jin, X; Yang, Q; Zhang, Z1

Other Studies

1 other study(ies) available for ginsenoside rh2 and honokiol

ArticleYear
A cocktail of betulinic acid, parthenolide, honokiol and ginsenoside Rh2 in liposome systems for lung cancer treatment.
    Nanomedicine (London, England), 2020, Volume: 15, Issue:1

    Topics: A549 Cells; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Betulinic Acid; Biphenyl Compounds; Cell Proliferation; Cisplatin; Ginsenosides; Humans; Lignans; Liposomes; Lung Neoplasms; Mice; Neoplasm Invasiveness; Pentacyclic Triterpenes; Sesquiterpenes; Triterpenes; Xenograft Model Antitumor Assays

2020